08:00 Registration opens

09:00 Opening remarks

Morning session, chaired by Stephen Harding (University of Nottingham, UK)

09:15 Stability of Biopharmaceuticals: Past, present and future
Paul Varley (Medimmune, UK)

09:45 Antibody glycoforms and stability
Roy Jefferis (University of Birmingham, UK)

10:15 Speed Networking

11:00 Primary packaging for biopharmaceuticals: challenges & options
Horst Koller (Schott, Switzerland)

11:30 Exhibitors highlight

12:15 Lunch Break, Exhibition and Posters

Afternoon session, chaired by Ahmed Yassin (GSK, UK)

13:30 Introduction

13:45 Developability evaluation during early pre-formulation: the meeting point between research and development
Bernardo Perez-Ramirez (Genzyme, USA)

14:15 Evaluation of chemical stability during developability assessment of therapeutic antibodies
Daniel Heitmann (Novartis, Switzerland)

14:45 Coffee break, Exhibition and Posters

15:15 Discussion panel: Challenges of setting specifications for biopharmaceutical products

16:15 Glycoconjugate vaccine stability and formulation
Chris Jones (NIBSC, UK)

16:45 Concluding remarks

17:00 Conference ends